Reply to: "Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints"

J Hepatol. 2024 Nov;81(5):e230-e231. doi: 10.1016/j.jhep.2024.07.012. Epub 2024 Jul 20.
No abstract available

Publication types

  • Letter